Finance
India, Africa-focused impact fund gets LP money from UK-based investor
A Swiss impact investment fund that has backed a handful of Indian companies, including an eye-care chain and a clean-energy ......
Finance
Most VCs to focus on existing portfolio firms, see valuation froth: VCCircle Survey
The mood of venture capital firms appears to have changed when it comes to adding new startups to their portfolio ......
Healthcare
Sector Watch: How PE-backed regional pathology chains stack up versus national peers
A few months after Thyrocare Technologies Ltd made a spectacular debut on stock exchanges, its founder A Velumani predicted that...
Finance
RTP Global's Kirill Kozhevnikov on bias towards early-stage bets, valuations and more
Russian venture capital firm RTP Global has just launched a $650 million fund, which is more than triple the size of ......
Healthcare
Eight Roads adds new venture partner to sharpen life sciences focus
Eight Roads Ventures has hired a venture partner, as the proprietary investment arm of Fidelity International Ltd seeks to strengthen...
Finance
Long way to go for local fund managers to adopt ESG goals: Panellists at VCCircle summit
Investors in the US and Europe may have started focusing on environmental, social and governance (ESG) factors but fund managers...
Healthcare
ChrysCapital injects more funds into drugmaker after returning as investor
Homegrown private equity firm ChrysCapital has pumped additional capital into a pharmaceutical company, barely weeks after coming...
People
Iron Pillar execs on funding gap at mid-stage level, exit pipeline, valuations and more
Iron Pillar is one of the few mid-stage tech investors in India. The venture capital firm, which launched its debut ......
Healthcare
Explained: How treating medical devices as ‘drugs' will affect companies, investors
From April, all medical devices sold in India will be treated as ‘drugs’. On Tuesday, the central government issued...
Healthcare
Kedaara Capital backs Gujarat life sciences firm in first pharma bet
Homegrown private equity firm Kedaara Capital has made its first pharmaceuticals bet with an investment in a bulk-drugs maker...
